ISM - MSBV- ALL - PAR_RETI - 2025-09-18

Summary by AI ^BETAClose X

Morgan Stanley B.V. announced a partial cancellation of several ISINs/CUSIPs. For XS2894051270, the unwind amount is 300,000.00, leaving an outstanding amount of 300,000.00, settling on September 19, 2025. XS2893951058 has an unwind amount of 300,000.00, with a remaining outstanding amount of 915,000.00, also settling on September 19, 2025. ISINs XS3043111932, XS3043112310 and XS3043112237 each have an unwind amount of 100,000.00, resulting in an outstanding amount of 100,000.00 each, settling on September 22, 2025. Finally, XS3043165862 has an unwind amount of 17,000.00, leaving an outstanding amount of 523,000.00, also settling on September 22, 2025.

Disclaimer*

Morgan Stanley B.V.

18 September 2025

Morgan Stanley & Co. International plc

25 Cabot Square

Canary Wharf

London E14 4QA, England

September 18, 2025

Notice of Partial Cancellation

Dear Sir/Madam:

Please note that there has been a Partial Cancellation by the issuer for the following ISIN(s) / CUSIP(s):

ISIN(s)/CUSIP(s)	Issuer	Unwind Amount	Outstanding Amount*	Settlement Date
XS2894051270	MORGAN STANLEY B.V.	300,000.00	300,000.00	19-Sep-25
XS2893951058	MORGAN STANLEY B.V.	300,000.00	915,000.00	19-Sep-25
XS3043111932	MORGAN STANLEY B.V.	100,000.00	100,000.00	22-Sep-25
XS3043112310	MORGAN STANLEY B.V.	100,000.00	100,000.00	22-Sep-25
XS3043112237	MORGAN STANLEY B.V.	100,000.00	100,000.00	22-Sep-25
XS3043165862	MORGAN STANLEY B.V.	17,000.00	523,000.00	22-Sep-25

*Outstanding Amount reflects the Outstanding Issuance Amount post notification event.

In case of any questions do not hesitate to contact us for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END